Source: ERJ Open Res, 6 (4) 00297-2019; 10.1183/23120541.00297-2019
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Michael McGettrick, Paul McCaughey, Alexander MacLellan, Melanie Brewis, A. Colin Church, Martin K. Johnson. Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease. ERJ Open Res, 6 (4) 00297-2019; 10.1183/23120541.00297-2019

Member's Comments

No comment yet.

Related content which might interest you: Chronic thromboembolic pulmonary hypertension Source: Eur Respir Mon 2012; 57: 108-118 Year: 2012 Risk assessment in severe pulmonary hypertension due to interstitial lung disease Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 Microvascular disease in chronic thromboembolic pulmonary hypertension: the story continues Source: Eur Respir J 2014; 44: 1121-1122 Year: 2014 Risk factors for chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2012; 21: 27-31 Year: 2012 Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Cardiovascular risk factors in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 624s Year: 2006 Autoantibodies are frequently found in arterial and chronic thrombotic pulmonary hypertension not associated to connective tissue diseases Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Chronic thromboembolic pulmonary hypertension: a distinct disease entity Source: Eur Respir Rev 2015; 24: 246-252 Year: 2015 ERS statement on chronic thromboembolic pulmonary hypertension Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension Year: 2021 Secondary pulmonary hypertension in chronic obstructive pulmonary disease and systemic lupus erythematosus- pathophysiology and treatment Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Risk factors for chronic obstructive pulmonary disease in women Source: Eur Respir J 2002; 20: Suppl. 38, 326s Year: 2002 Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption Year: 2016 Epidemiology of chronic obstructive pulmonary disease Source: Eur Respir J 2001; 17: 982-994 Year: 2001 Genetic risks in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 454s Year: 2003 Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 453s Year: 2006 Risk factors for pulmonary hypertension and associations with lung function in connective tissue diseases Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010 Cardiovascular comorbidity and mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD epidemiology Year: 2012 Systemic vascular function in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013